Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Malaysian Mountain Climbing Icon Ravi Everest Joins 9th Annual Expedition Mt. Kinabalu to Raise Awareness for Duchenne Muscular Dystrophy

Organizers highlight ongoing Duchenne research at Kuala Lumpur Hospital and University Malaya Medical Centre


News provided by

Coalition Duchenne

Jul 18, 2019, 22:00 ET

Share this article

Share toX

Share this article

Share toX

Catherine Jayasuriya on Mt Kinabalu
Catherine Jayasuriya on Mt Kinabalu

NEWPORT BEACH, Calif., July 18, 2019 /PRNewswire-PRWeb/ -- World renowned two-time Everest summiter Ravichandran Tharumalingam, who is also known as "Ravi Everest," will be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in Sabah, Malaysia, to be held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy and was founded by Sabahan Catherine Jayasuriya.

Jayasuriya, who lives in California, grew up in Kota Kinabalu and always dreamed of taking her children to the summit of its sentinel mountain. Her son, Dusty Brandom, has Duchenne and would never make the climb. At 26, Dusty is in a wheelchair and severely impacted by the muscle wasting disease. He travelled to Sabah in 2011 to visit his grandfather Tan Sri Thomas Jayasuriya but is now too physically impacted to make the long journey.

Dusty is my daily inspiration and he inspires everyone he knows as he overcomes personal adversity with a smile on his face

Post this

"Their bodies fail them but their mind and dreams are strong," said Jayasuriya. "Dusty is my daily inspiration and he inspires everyone he knows as he overcomes personal adversity with a smile on his face. I climb for him."

Dusty and the challenges faced by boys and young men with Duchenne have inspired Ravi Everest to become involved with the cause. His global ambitions match Coalition Duchenne's goal of raising global awareness about Duchenne. Ravi Everest has climbed mountains all over the world proudly flying the Malaysian flag. He is currently working on the "Seven Summits Challenge," which is a quest to climb the highest mountains on each continent, as well as the "Eight Thousander" challenge of climbing all 14 mountains over 8,000 meters. To top it all he is committed to achieving the "Grand Slam," which adds the North Pole and the South Pole to the Seven Summits.

Ravi Everest has successfully conquered Mt. Everest twice, once in 2006 and again in 2007. Throughout his climbs he has endured many challenges, such as near-death in an avalanche on Mt. Manaslu, in Nepal in 2012, and losing eight fingers to frostbite on Everest in 2006. Despite these challenges, he continues to push himself to climb the most challenging mountains and inspire others. As a motivational speaker, Ravi wishes to inspire everyone to achieve the summit of their dreams.

Jayasuriya believes strongly in acting locally but thinking globally. She is an advocate for Malaysian patients to have access to drugs for Duchenne currently being developed in the US and Europe.

"Boys and young men with Duchenne in this region need a voice and access to new drugs," said Catherine.

Validating Jayasuriya's advocacy, a pioneering Duchenne clinical trial is recruiting patients at two sites in Malaysia. PTC Therapeutics, a US-based biopharmaceutical company, is the sponsor of the clinical trial. Investigators are looking for boys with Duchenne aged five and above who still have the ability to walk. The study examines whether the PTC drug ataluren can delay Duchenne progression and maintain patients' ability to walk, run, and climb up and down stairs over a period of 144 weeks. The safety of ataluren is also being assessed.

The Principal Investigators at the two clinical trial sites in Malaysia are Teik Beng Khoo, MD at Kuala Lumpur Hospital, and Meow Keong Thong, MD at University Malaya Medical Centre.

It is hoped that the results of this trial will drive better understanding of Duchenne and its treatment, and ultimately benefit future patients.

Dusty and his 93-year-old grandfather, Tan Sri Thomas Jayasuriya, are featured in Catherine Jayasuriya's award-winning film Dusty's Trail: Summit of Borneo. The film is the story of Dusty's journey with Duchenne, and it tells about people coming together from around the world to climb Mt. Kinabalu to raise awareness. Dusty's Trail has an important message of hope in the face of adversity, and shows the beauty of Sabah and its people to the world.

"I'm inspired by the determination of boys and young men with Duchenne like Dusty," said Ravi Everest.

SOURCE Coalition Duchenne

Modal title

Catherine Jayasuriya on Mt Kinabalu
Catherine Jayasuriya on Mt Kinabalu
Catherine Jayasuriya on Mt Kinabalu
Catherine Jayasuriya on Mt Kinabalu
Catherine Jayasuriya on Mt Kinabalu Catherine Jayasuriya on Mt Kinabalu

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.